OBJECTIVES: Diabetes mellitus (DM) and renal impairment (RI) are both independent predictors of mortality after coronary artery bypass graft surgery (CABG). The two conditions often coexist, yet the impact on long-term prognosis after CABG of each factor relative to the other and the two in combination is uncertain.
INTRODUCTION
Patients with diabetes mellitus (DM) are three to four times more likely to die of ischaemic heart disease than of any other single condition [1] . Diabetic patients are particularly prone to diffuse, multivessel coronary artery disease (CAD) [2] , for which current guidelines recommend coronary artery bypass graft surgery (CABG) as the myocardial revascularization modality of choice [3] . Furthermore, diabetic patients with multivessel CAD appear to derive a survival advantage from CABG compared with percutaneous coronary intervention (PCI) which is not present in nondiabetic patients. [4] . For these reasons, the proportion of patients undergoing CABG who have DM has increased steadily over the last 15 years, diabetic patients now accounting for approximately one quarter of patients undergoing CABG [5, 6] .
More than 40% of adults with DM have renal impairment (RI) characterized by either albuminuria or reduced glomerular filtration rate [7] . Both DM and RI are predictors of increased mortality following CABG [8] [9] [10] . However, despite the common coexistence of these two conditions, there are few data that describe the impact on prognosis after CABG of each factor relative to the other and the two in combination. In this prospective, single
METHODS

Patients and setting
Between 1 January 2003 and 31 December 2007, 4991 patients underwent isolated CABG at Barts Health NHS Trust. All patients were included in the study except for 87 patients who had incomplete surgical datasets and 35 patients who required renal replacement therapy (haemodialysis or peritoneal dialysis) preoperatively. These patients were excluded from the analysis leaving 4869 patients in the study cohort (Fig. 1) .
Data collection
Detailed clinical information was recorded prospectively and stored electronically. Baseline clinical data included age, sex, body mass index (BMI), symptom status, history of myocardial infarction (MI), PCI, DM, hypertension, peripheral vascular disease (PVD) or stroke, and preoperative renal function, left ventricular function, anatomical severity of CAD and the logistic EuroSCORE [11] . Diabetes was defined as the requirement for dietary modification, oral medication and/or insulin to lower blood glucose concentrations and was accepted as present based upon the patient's history corroborated where possible by the medical records.
Operative data recorded included procedural urgency, use of cardiopulmonary bypass (CPB), internal mammary arterial (IMA) grafts, intra-aortic balloon pump (IABP), cross-clamp time and perfusion time. Urgent surgery was defined by the requirement for the patient to remain in hospital for CABG following coronary angiography. Elective surgery was defined as CABG in patients who were discharged from the hospital following coronary angiography and readmitted in a planned way for surgery at a later date.
Postoperative complications that were recorded included in-hospital stroke, need for resternotomy (for bleeding), sternal wound infection and postoperative acute kidney injury (AKI).
Renal function
Serum creatinine concentration was measured preoperatively in all study patients. For patients undergoing elective surgery, the serum creatinine concentration was measured in a preadmission clinic approximately 4 weeks before surgery. For patients undergoing urgent surgery, the serum creatinine concentration was measured on admission to hospital. The estimated glomerular filtration rate (eGFR) was calculated from the Modification of Diet in Renal Disease equation [12] . RI was defined as an eGFR <60 ml/min. Serum creatinine levels were measured daily for the first postoperative week unless patients were discharged within this period. Postoperative AKI was defined as a 50% increase in serum creatinine concentration within 7 days of surgery compared with the preprocedure level.
Outcomes
The primary study end point was mid-term all-cause mortality (measured at 5 years). The secondary study end point was 30-day postoperative mortality. Mortality data were obtained from the United Kingdom Office of National Statistics, which periodically links live/death status of treated patients to our unit's surgical database as part of the national Central Cardiac Audit Database. 
Ethics
Data were collected routinely as part of a national cardiac surgical audit and patient identifiers were removed prior to analysis. The local ethics committee advised us that formal ethical approval was not required for this study.
Statistical analysis
The cohort was divided into four groups according to preoperative diabetic status and renal function for analysis: patients without either DM or RI (reference group), patients with DM alone, patients with RI alone and patients with both DM and RI. Baseline clinical characteristics and procedural data were compared between the groups. Categorical data are summarized using absolute values ( percentage). Continuous data with a normal distribution are presented as mean ± standard deviation or, where skewed, as median (IQR). Normally distributed data were compared through a one-way analysis of variance and non-normally distributed variables were compared through the Kruskal-Wallis test. Categorical data were compared using the Pearson χ 2 test. Procedural outcomes, 30-day mortality and 5-year mortality were compared between the four groups. Potential independent associations between DM, RI and DM/RI and 30-day mortality were assessed using multivariate logistic regression. Mid-term survival was described using the Kaplan-Meier method, and comparisons between groups were made using the log-rank statistic. Variables associated with 5-year mortality were analysed using multivariable Cox proportional regression in order to account for confounding factors. Interaction between DM and RI was assessed using an interaction effect model based on the Cox proportional regression model but entering DM and RI into the model as categorical variables. A P-value of <0.05 was considered statistically significant. Statistical analyses were performed using SPSS version 18.0 (SPSS, Inc.).
RESULTS
Patient demographics and operative characteristics
The baseline clinical characteristics of the study groups are given in Table 1 . Among 4869 patients who underwent CABG, 1054 (21.6%) had DM, 1042 (21.4%) had preoperative RI and 461 (9.5%) had both. The mean eGFR in the RI group was 48.7 ± 8.7 ml/min and 47.8 ± 9.7 ml/min in the DM/RI group. Compared with the reference group, diabetic patients had the highest average BMI and the highest frequency of hypertension and prior PCI. Patients with RI were significantly older, more often female and had a higher average logistic EuroSCORE. Patients who had both DM and RI were older and were significantly more likely than the reference group to have class III-IV angina or heart failure, prior MI or stroke, PVD, left ventricular impairment, three vessel or left main stem CAD, and had the highest mean logistic EuroSCORE. Patients in the DM/RI group were also the most likely to undergo urgent surgery and to require the use of a perioperative IABP, and least commonly received an IMA graft. 
Postoperative complications and 30-day mortality
The in-hospital complications and 30-day mortality data are given in Table 2 . AKI developed in 629 (12.9%) patients. The rate was 7.7% in the reference group, 15.7% in the DM group, 15.8% in the RI group and 26.5% in the DM/RI group (P < 0.0001). The rates of postoperative dialysis, stroke and prolonged hospital stay were also highest in the DM/RI group. The 30-day mortality rates were 0.9% (reference group), 1.3% (DM group), 3.7% (RI group) and 3.9% (DM/RI group) (P < 0.0001). Univariate logistic regression confirmed both RI and DM/RI, but not DM as predictors of 30-day mortality post-CABG, when compared with the reference group. The association between 30-day mortality and RI (odds ratio (OR) 2.84; 95% CI 1.55-5.21) and DM/RI (OR 2.46; 95% CI 1.23-4.90), respectively, persisted after multivariate analysis (Table 3) . Increasing age, hypertension and use of a perioperative IABP were also independently associated with higher rates of 30-day mortality while use of an IMA graft was associated with lower 30-day mortality.
Five-year all-cause mortality
Kaplan-Meier analysis (Fig. 2 ) showed significant differences between the study groups in mortality rates during the mid-term follow-up after CABG. The 1-year mortality rates in the reference group, DM group, RI and DM/RI group were 2.3% (95% CI 0.7-5.6), 3.5% (95% CI 1.0-8.9), 8.5% (95% CI 4.8-13.6) and 12.0% (95% CI 6.3-19.6), respectively (P < 0.0001). The 5-year mortality rates were 9.0% (95% CI 6.3-12. The other significant independent associations with higher rates of 5-year all-cause mortality were increasing age, PVD, preoperative left ventricular ejection fraction <50% and need for urgent surgery. There was no significant interaction between DM and RI upon 5-year mortality (P = 0.083).
DISCUSSION
In this single-centre cohort study of more than 4000 patients who underwent isolated CABG, there were significantly higher 30-day and 5-year mortality rates in patients who had preoperative RI compared with patients without preoperative RI. The prognostic disadvantage associated with RI was present irrespective of diabetic status, but the mortality rates were highest in patients who were also diabetic. Previous studies have shown that DM and RI are individually associated with increased long-term mortality after CABG [8] [9] [10] 13] . There are few data, however, which have examined the prognostic impact of each factor relative to the other and the two in combination. Furthermore, the interpretation of previous studies is complicated by the high mortality rates among patients who are established on dialysis preoperatively, a group which we therefore excluded. In this study, the 5-year mortality rate was approximately twice as high in non-diabetic patients with RI and 3-fold higher in diabetic patients with RI compared with patients without RI. The presence or absence of DM appeared to have little impact on short-or mid-term prognosis in patients without RI, but it was an important factor in determining the long-term prognosis after CABG in patients who did have RI.
We speculated that the main driver for the adverse 5-year outcomes following CABG in patients with the combination of RI and DM might be more advanced levels of RI in this group. Secondary analysis, however, showed that there was no difference between these patients and patients with RI alone either in mean eGFR or in the proportion of patients with eGFR 60-46, 45-30 and <30 ml/ min. The increased mortality in patients with both DM and RI cannot therefore be explained simply through more severe renal disease in these patients.
The patients with preoperative RI were older, had an elevated procedural risk and less commonly received an IMA graft compared with other patients. In addition, patients with RI and DM were also more likely than the reference group to have severe angina or heart failure, prior stroke, PVD, left ventricular impairment and left main stem CAD. These differences potentially confound the association between mortality and RI with or without DM that was identified in this study. After accounting for the differences between patient groups, the presence of either DM or RI was associated with an approximately 30% increase in the risk of 5-year mortality, while the combination of DM and RI doubled the risk compared with patients with neither condition. This is more than would be expected by simply adding the risk associated with DM and RI alone. However, we did not identify a significant statistical interaction between DM and RI.
RI was an important determinant of early outcomes after CABG, 30-day mortality rates increasing from 0.9% in reference patients and 1.3% in diabetic patients, to 3.7% in patients with RI alone and 3.9% in patients with both RI and DM. In this study, therefore, diabetic patients only had a significantly worse short-term outcome than non-diabetic patients if they had RI. These patients had higher surgical risk profiles and RI appeared to be a marker of the burden of cardiovascular disease and other comorbidities in diabetic patients. After accounting for potential confounding factors, RI increased the odds of death at 30 days by 2.84 (95% CI 1.55-5.21) with no additional impact from diabetes. The increased mortality associated with DM occurred late, well after hospital discharge. These observations suggest that it is the presence of end-organ damage in diabetic patients rather than the diabetes itself that influences early outcomes after CABG. Patients with 'uncomplicated' diabetes should expect short-term mortality rates similar to those of non-diabetic patients. In contrast, diabetic patients were at increased risk of AKI in comparison with the reference patient group whether or not they had preoperative RI. However, AKI occurred most commonly in patients with DM and RI in whom the frequency was 26.5%. This group also had the highest requirement for postoperative dialysis. Postoperative dialysis has been associated with mortality rates exceeding 60% [14] . AKI not requiring dialysis has also been associated with increased long-term mortality [15] . Furthermore, in this study, AKI was associated with significantly longer hospital stays. It seems likely that this was at least partly due to the need for prolonged monitoring of renal function in affected patients.
Comparisons with previous studies
A recent meta-analysis of 24 studies which included 28 168 diabetic patients with or without RI confirmed DM as an independent predictor of 30-day and 5-year mortality after CABG [10] . In this meta-analysis, the 30-day mortality was 3.3% in patients with DM and 2.2% in patients without DM. This compares with a 30-day mortality of 2.1% in our diabetic cohort and 1.8% in our non-diabetic cohort. In this meta-analysis 5-year mortality was 18.5% in patients with DM and 11.3% in patients without DM, compared with a mortality of 16.5% in our diabetic cohort and 12.8% in our non-diabetic cohort. In our cohort, DM without RI was associated with increased mid-term mortality but not increased 30-day mortality.
In an analysis of the Society of Thoracic Surgeons National Adult Cardiac Database that included approximately 500 000 patients stratified by eGFR, 30-day mortality following CABG was 4.7% for patients with an eGFR <60 ml/min compared with 1.7% in patients with eGFR ≥60 ml/min. This compares with a 30-day mortality in our surgical cohort of 3.8% in patients with an eGFR <60 ml/min and 1.0% in patients with an eGFR >60 ml/min. The long-term outcomes of patients with RI (defined by eGFR) after CABG are less well defined. A study of more than 6000 patients [16] reported 5-year mortality rates of 16.2% for patients with eGFR <60 ml/min compared with 7.7% in patients with a normal eGFR. In our cohort, 5-year mortality was 22.9% in patients with an eGFR <60 ml/min and 9.7% in patients with an eGFR >60 ml/min.
Strengths and limitations
This study assessed short-and mid-term outcomes in a large contemporary cohort of consecutive patients who underwent CABG. The only exclusion was preoperative dialysis patients and the primary study end point was all-cause mortality tracked by the Office for National Statistics, a robust clinical end point. Indeed, in an era of large registries, a particular strength of this study is the completeness of our follow-up mortality data. The results are therefore likely to offer genuine insights into the relation between DM, RI and the two in combination and 5-year mortality after CABG. Data regarding the specific cause of death, however, were not available.
This study suffers from the same limitations as all observational studies. We have already acknowledged that there were significant differences in baseline and operative characteristics between patient groups. Specifically, patients with RI, particularly those who were diabetic, were older and had a higher burden of comorbidities than other patients. This is the reality of these patients. Prospective data collection together with multivariate analyses allowed us to mitigate the effect of confounding on the relation between renal function, DM and mortality. However, there remains the possibility of residual confounding from unmeasured variables. These include the type of treatment received by the diabetic patients and the medical therapy for all patients following discharge. Insulin-treated diabetics have poorer survival following CABG than patients treated with oral agents or diet [17] [18] [19] , while patients with RI are less likely to receive prognostically beneficial medical therapies [20] .
Complete data concerning preoperative characteristics or clinical outcomes during the follow-up were not available for 87 (1.7%) patients who underwent CABG during the study period, so these patients were excluded from the analysis. It is possible that these exclusions introduced a selection bias to the study but the excluded patients were evenly distributed among the four study groups and the low rate of exclusions makes an important selection bias unlikely.
In this study, preoperative RI was defined by a single measurement of eGFR. We did not record whether or not proteinuria was present. Proteinuria is a well-established independent predictor of cardiovascular mortality [21] and has been shown to be an independent predictor of adverse prognosis in diabetic patients undergoing CABG [22] . Furthermore, the definition of RI in this way did not allow us to identify patients who might have had transient acute renal dysfunction following acute MI complicated by left ventricular dysfunction or following recent coronary angiography, a clinical variable that is known to affect prognosis adversely following cardiac surgery. In our cohort, most of the patients were elective cases without any reason for AKI. Furthermore, we can conclude that RI irrespective of its duration was associated with increased mortality at 30 days and 5 years.
Implications for practice
This study has helped to clarify the impact of DM and RI on mid-term prognosis after CABG. Patients with DM but no RI had only slightly higher mid-term mortality rates than patients without DM or RI. Patients with RI alone fared considerably worse than those without RI though this was partly accounted for by their older age. After accounting for the differences between the patient groups, DM alone and RI alone both conferred an excess mid-term mortality of about 30%. Patients with both RI and DM had by far the highest mid-term mortality rate at 28.8%. This partly reflected their greater frequency of comorbidities, but after adjusting for these, the combination of RI and DM conferred a 2-fold increase in mid-term risk. One can speculate that the excess mortality was partly due to the more frequent occurrence of diffuse, calcific CAD in these patients with its negative implications for technical success, graft run-off and graft patency rates. The PCI enthusiast might see these data as a reason to consider PCI in patients with DM and RI, but the unfavourable characteristics of the coronary artery walls are just as much a challenge to the interventional cardiologist as to the cardiac surgeon, while the risk of contrast-induced nephropathy is highest in this group of patients [23] . Nor was this a comparative trial of treatment strategies so these data do not imply that patients with DM and/or RI do not benefit prognostically from CABG. Randomized controlled trials comparing CABG with PCI in diabetic patients with multivessel disease have consistently shown reduced rates of major adverse cardiac events in the CABG group, driven by lower rates of repeat revascularization [24] , while the future revascularization evaluation in patients with diabetes mellitus: optimal management of multi-vessel disease trial also reported significantly lower 5-year rates of death and MI in patients treated by CABG [25] .
Our data are useful to cardiologists and cardiac surgeons when discussing the expected outcomes after surgery with their patients. Furthermore, this information is relevant to a significant proportion of patients undergoing CABG. In this unselected study population, for example, half of the patients had DM, RI or both.
CONCLUSIONS
Preoperative DM and RI are important predictors of 5-year mortality after CABG. Patients with RI alone had a higher mortality rate than patients with DM alone, but this difference was largely accounted for by age and other comorbidities. The combination of DM and RI doubled the 5-year mortality rate after CABG independently of potential confounding factors.
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